We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Procalcitonin Level and Kinetics in Children With Bacterial Infections

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00714402
First Posted: July 14, 2008
Last Update Posted: May 18, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shaare Zedek Medical Center
  Purpose

The purposes of this study are:

  1. To determine whether procalcitonin level at admission of pediatric patients with bacterial infections can be used as a marker for prediction of defervescence and hospitalization length
  2. To examine the kinetics of procalcitonin in pediatric patients with bacterial infections and persistent fever

Condition
Bacterial Infections Bacteremia Meningitis Urinary Tract Infection Mastoiditis Lobar Pneumonia Septic Arthritis Cellulitis Osteomyelitis

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Procalcitonin Level as a Prognostic Marker and Its' Kinetics in Children With Bacterial Infections

Resource links provided by NLM:


Further study details as provided by Shaare Zedek Medical Center:

Primary Outcome Measures:
  • time to defervescence [ Time Frame: discharge ]

Secondary Outcome Measures:
  • length of hospitalization [ Time Frame: discharge ]

Biospecimen Retention:   None Retained
whole blood

Estimated Enrollment: 50
Study Start Date: August 2008
Groups/Cohorts
a
children with proven of probable invasive bacterial infections

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
hospitalized patients at date of admission
Criteria

Inclusion Criteria:

  • Positive blood, urine, synovial, bone, pleural effusion, abscess or CSF culture
  • Cellulitis, lobar pneumonia, osteomyelitis,
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00714402


Locations
Israel
Shaare Zedek Medical Center
Jerusalem, Pob 3235, Israel, 91031
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Yechiel Schlesinger, MD Shaare Zedek Medical Center
  More Information

Publications:

Responsible Party: Yechiel Schlesinger, Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT00714402     History of Changes
Other Study ID Numbers: pct.ctil
First Submitted: July 9, 2008
First Posted: July 14, 2008
Last Update Posted: May 18, 2011
Last Verified: January 2009

Keywords provided by Shaare Zedek Medical Center:
UTI

Additional relevant MeSH terms:
Infection
Communicable Diseases
Pneumonia
Urinary Tract Infections
Meningitis
Bacterial Infections
Bacteremia
Cellulitis
Osteomyelitis
Arthritis, Infectious
Mastoiditis
Lung Diseases
Respiratory Tract Diseases
Respiratory Tract Infections
Urologic Diseases
Central Nervous System Diseases
Nervous System Diseases
Sepsis
Systemic Inflammatory Response Syndrome
Inflammation
Pathologic Processes
Skin Diseases, Infectious
Suppuration
Connective Tissue Diseases
Bone Diseases, Infectious
Bone Diseases
Musculoskeletal Diseases
Arthritis
Joint Diseases
Otitis Media